Search - tctmd.com

Displaying 321 - 340 of 629

Sort: Relevancy | Date

News Daily News

The Hunt for Protein Culprits in COVID-19’s Cardiac Complications

Michael O'Riordan

May 06, 2022

News Conference News HRS 2022

Evidence Grows for Conduction-System Pacing as an Alternative to CRT

Todd Neale

May 05, 2022

News Daily News

DELIVER Trial Scores a Win for Dapagliflozin in HFpEF

L.A. McKeown

May 05, 2022

News Daily News

Frailty Does Not Hinder Dapagliflozin’s HFrEF Impact: DAPA-HF Analysis

Caitlin E. Cox

May 03, 2022

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for April 2022

Shelley Wood

May 02, 2022

News Conference News HRS 2022

Gains in HF Drug Therapy Raise Questions About ICD Benefit in Modern Era

Todd Neale

May 02, 2022

News Daily News

Medtronic’s HeartWare HVAD Recalled for Pump Weld Defect

L.A. McKeown

April 29, 2022

News Daily News

Underuse of GDMT for Heart Failure Even Worse in Low-Income Countries

Todd Neale

April 20, 2022

News Daily News

Revascularization’s Benefits in HFrEF Linked to Gains in LV Function

Caitlin E. Cox

April 15, 2022

News Daily News

Cardiac Complications Higher After COVID-19 Than Vaccination

Shelley Wood

April 14, 2022

News Daily News

Myopericarditis No More Common After COVID-19 Shots Than Other Vaccines

Caitlin E. Cox

April 12, 2022

News Conference News ACC 2022

DIAMOND Shines Bright on Patiromer for Curbing Hyperkalemia in HFrEF

L.A. McKeown

April 08, 2022

News Conference News ACC 2022

Mavacamten Yields Stable Benefits in Obstructive HCM Over Longer Term

Shelley Wood

April 03, 2022

Seasonal, but No Year-round, Protection With Flu Shots in HF: IVVE

News Conference News ACC 2022

Seasonal, but No Year-round Help for HF With Flu Shots: IVVE

Yael L. Maxwell

April 03, 2022

News Opinion CV Team Dispatch

April 2022 News Roundup

L.A. McKeown

April 01, 2022

News Daily News

A ‘Call to Action’ for HF Trials: More Black, Hispanic Patients

Caitlin E. Cox

March 31, 2022

News Conference News ACC 2022

What’s Going to Be Hot at ACC 2022, In Person or Virtual

Shelley Wood

March 28, 2022

News Daily News

Empagliflozin Plus an MRA Is Safe in HFpEF, May Help With Hyperkalemia

L.A. McKeown

March 22, 2022

News Daily News

Guideline-Directed Therapies Underused in Frail HF Patients

L.A. McKeown

March 11, 2022

News Daily News

Skipping Low-Value Cardiovascular Care Could Save Billions: AHA

Michael O'Riordan

March 01, 2022

Advertisement

The Hunt for Protein Culprits in COVID-19’s Cardiac Complications

Evidence Grows for Conduction-System Pacing as an Alternative to CRT

DELIVER Trial Scores a Win for Dapagliflozin in HFpEF

Frailty Does Not Hinder Dapagliflozin’s HFrEF Impact: DAPA-HF Analysis

TCTMD’s Top 10 Most Popular Stories for April 2022

Gains in HF Drug Therapy Raise Questions About ICD Benefit in Modern Era

Medtronic’s HeartWare HVAD Recalled for Pump Weld Defect

Underuse of GDMT for Heart Failure Even Worse in Low-Income Countries

Revascularization’s Benefits in HFrEF Linked to Gains in LV Function

Cardiac Complications Higher After COVID-19 Than Vaccination

Myopericarditis No More Common After COVID-19 Shots Than Other Vaccines

DIAMOND Shines Bright on Patiromer for Curbing Hyperkalemia in HFrEF

Mavacamten Yields Stable Benefits in Obstructive HCM Over Longer Term

Seasonal, but No Year-round Help for HF With Flu Shots: IVVE

April 2022 News Roundup

A ‘Call to Action’ for HF Trials: More Black, Hispanic Patients

What’s Going to Be Hot at ACC 2022, In Person or Virtual

Empagliflozin Plus an MRA Is Safe in HFpEF, May Help With Hyperkalemia

Guideline-Directed Therapies Underused in Frail HF Patients

Skipping Low-Value Cardiovascular Care Could Save Billions: AHA

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content